HU169159B - - Google Patents

Info

Publication number
HU169159B
HU169159B HUAO365A HUAO000365A HU169159B HU 169159 B HU169159 B HU 169159B HU AO365 A HUAO365 A HU AO365A HU AO000365 A HUAO000365 A HU AO000365A HU 169159 B HU169159 B HU 169159B
Authority
HU
Hungary
Application number
HUAO365A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU169159B publication Critical patent/HU169159B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • C07K5/06095Arg-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • C07K14/6955Corticotropin [ACTH] with at least 1 amino acid in D-form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUAO365A 1972-05-24 1973-05-23 HU169159B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7206941,A NL175988C (nl) 1972-05-24 1972-05-24 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.

Publications (1)

Publication Number Publication Date
HU169159B true HU169159B (en:Method) 1976-10-28

Family

ID=19816103

Family Applications (1)

Application Number Title Priority Date Filing Date
HUAO365A HU169159B (en:Method) 1972-05-24 1973-05-23

Country Status (13)

Country Link
US (1) US3850904A (en:Method)
JP (1) JPS5747667B2 (en:Method)
AU (1) AU470908B2 (en:Method)
BE (1) BE799939A (en:Method)
CA (1) CA1030954A (en:Method)
CH (1) CH587229A5 (en:Method)
DE (1) DE2326033C2 (en:Method)
FR (1) FR2185412B1 (en:Method)
GB (1) GB1435384A (en:Method)
HU (1) HU169159B (en:Method)
NL (1) NL175988C (en:Method)
SE (1) SE407215B (en:Method)
ZA (1) ZA733211B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438029A (en) 1978-01-19 1984-03-20 Research Corporation Synthetic peptides
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
NL8101724A (nl) * 1981-04-08 1982-11-01 Akzo Nv Peptiden met zenuw-regenererende eigenschappen.
US4500713A (en) * 1982-09-23 1985-02-19 Usv Pharmaceutical Corporation Therapeutic dipeptides
WO1986003746A1 (en) * 1984-12-14 1986-07-03 La Trobe University Amino acid and peptide inhibitors of human leucocytic elastase
WO2011133348A1 (en) 2010-04-21 2011-10-27 Pharmacofore, Inc. Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof
US12384744B2 (en) 2021-09-29 2025-08-12 Ensysce Biosciences Inc. Enzyme-cleavable methadone prodrugs and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1302396A (fr) * 1961-03-10 1962-08-31 Ciba Geigy Procédés de préparation de nouveaux heptapeptides de formule l-alpha-[mercaptoalcoyl (inférieur)]-alpha-amino-acétyl-l-glutaminyl-l-histidyl-l-phényl alanyl-l-alpha-[amino-alcoyl (inférieur)]-alpha-amino-acétyl-l-tryptophyl glycine
NL6509727A (en:Method) * 1965-07-28 1967-01-30
GB1301738A (en:Method) * 1969-07-09 1973-01-04

Also Published As

Publication number Publication date
DE2326033A1 (de) 1973-12-20
JPS4948666A (en:Method) 1974-05-11
ZA733211B (en) 1974-04-24
AU470908B2 (en) 1976-04-01
FR2185412A1 (en:Method) 1974-01-04
GB1435384A (en) 1976-05-12
NL7206941A (en:Method) 1973-11-27
AU5575073A (en) 1974-11-21
CH587229A5 (en:Method) 1977-04-29
DE2326033C2 (de) 1983-10-27
FR2185412B1 (en:Method) 1976-12-03
NL175988C (nl) 1985-02-01
BE799939A (fr) 1973-11-23
SE407215B (sv) 1979-03-19
CA1030954A (en) 1978-05-09
US3850904A (en) 1974-11-26
NL175988B (nl) 1984-09-03
JPS5747667B2 (en:Method) 1982-10-12

Similar Documents

Publication Publication Date Title
FR2185412B1 (en:Method)
CH577304A5 (en:Method)
BG19031A1 (en:Method)
CH1468172A4 (en:Method)
CH1524672A4 (en:Method)
CH52272A4 (en:Method)
CH559254A5 (en:Method)
CH559400A5 (en:Method)
CH559453A5 (en:Method)
CH559552A5 (en:Method)
CH562719A5 (en:Method)
CH562780A5 (en:Method)
CH563077A5 (en:Method)
CH563336A5 (en:Method)
CH563418A5 (en:Method)
CH563920A5 (en:Method)
CH564523A5 (en:Method)
CH564534A5 (en:Method)
CH564775A5 (en:Method)
CH564828A5 (en:Method)
CH565085A5 (en:Method)
CH565100A5 (en:Method)
CH565418A5 (en:Method)
CH565431A5 (en:Method)
CH566178A5 (en:Method)